Edit |   |
---|---|
Antigenic Specificity | IL17A, Human (Secukinumab biosimilar) |
Clone | Secukinumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL17A Recombinant Antibody (Secukinumab). Secukinumab, sold under the brand name Cosentyx, is a human IgG1 monoclonal antibody that binds to the protein interleukin (IL)-17A, and is marketed by Novartis for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It inhibits a member of the cytokine family, interleukin 17A. |
Immunogen | n/a |
Other Names | Anti-IL17A Recombinant Antibody, Research Grade Secukinumab, Anti-Human IL17A Recombinant Antibody(Secukinumab), AIN457, Antibody Drug Analogues, Monoclonal Antibody, YR1220, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1229022-83-6 |
Catalog # | YR1220 |
Price | please inquire |
Order / More Info | IL17A, Human (Secukinumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |